blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3810630

EP3810630 - PEPTIDE LIGANDS FOR BINDING TO IL-17 [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  04.08.2023
Database last updated on 11.09.2024
FormerExamination is in progress
Status updated on  25.11.2022
FormerRequest for examination was made
Status updated on  26.03.2021
FormerThe international publication has been made
Status updated on  27.12.2019
Formerunknown
Status updated on  02.07.2019
Most recent event   Tooltip05.08.2023New entry: Additional fee for renewal fee: despatch of communication + time limit 
Applicant(s)For all designated states
BicycleTX Limited
B900, Babraham Research Campus
Cambridge, CB22 3AT / GB
[2021/17]
Inventor(s)01 / TEUFEL, Daniel
Meditrina Building c/o Bicycle Therapeutics
Limited Babraham Research Campus
Cambridge, CB22 3AT / GB
02 / MUDD, Gemma
Meditrina Building c/o Bicycle Therapeutics
Limited Babraham Research Campus
Cambridge, CB22 3AT / GB
03 / PAVAN, Silvia
Meditrina Building c/o Bicycle Therapeutics
Limited Babraham Research Campus
Cambridge, CB22 3AT / GB
 [2021/17]
Representative(s)Maschio, Antonio
Maschio & Soames IP Limited
30 Carlton Crescent
Southampton SO15 2EW / GB
[2021/17]
Application number, filing date19732593.918.06.2019
[2021/17]
WO2019EP66060
Priority number, dateGB2018001032722.06.2018         Original published format: GB 201810327
[2021/17]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2019243350
Date:26.12.2019
Language:EN
[2019/52]
Type: A1 Application with search report 
No.:EP3810630
Date:28.04.2021
Language:EN
The application published by WIPO in one of the EPO official languages on 26.12.2019 takes the place of the publication of the European patent application.
[2021/17]
Search report(s)International search report - published on:EP26.12.2019
ClassificationIPC:C07K7/08, A61K47/64
[2021/17]
CPC:
C07K7/08 (EP,US); A61K47/64 (EP,US); A61K38/00 (US)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2021/17]
TitleGerman:PEPTIDLIGANDEN ZUR BINDUNG AN IL-17[2021/17]
English:PEPTIDE LIGANDS FOR BINDING TO IL-17[2021/17]
French:LIGANDS PEPTIDIQUES SE LIANT À IL-17[2021/17]
Entry into regional phase14.01.2021National basic fee paid 
14.01.2021Designation fee(s) paid 
14.01.2021Examination fee paid 
Examination procedure14.01.2021Examination requested  [2021/17]
14.01.2021Date on which the examining division has become responsible
29.07.2021Amendment by applicant (claims and/or description)
25.11.2022Despatch of a communication from the examining division (Time limit: M04)
06.04.2023Application deemed to be withdrawn, date of legal effect  [2023/36]
02.05.2023Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2023/36]
Fees paidRenewal fee
08.06.2021Renewal fee patent year 03
07.06.2022Renewal fee patent year 04
Penalty fee
Additional fee for renewal fee
30.06.202305   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[Y]WO2009098450  (MEDICAL RES COUNCIL [GB], et al) [Y] 1-19 * page 20 - page 21; figures 15A, 15B *;
 [Y]WO2016067035  (BICYCLE THERAPEUTICS LTD [GB]) [Y] 1-19 * page 10 - page 14; claims 1-41 *;
 [XDP]WO2018115203  (BICYCLERD LTD [GB]) [XDP] 1-5,13-19* figures 3-6,10-13; claims 1-23 *;
 [Y]  - KALE SANGRAM S ET AL, "Cyclization of peptides with two chemical bridges affords large scaffold diversities", NATURE CHEMISTRY, NATURE PUBLISHING GROUP UK, LONDON, vol. 10, no. 7, doi:10.1038/S41557-018-0042-7, ISSN 1755-4330, (20180430), pages 715 - 723, (20180430), XP036530421 [Y] 1-19 * abstract * * page 720; figures 2,3,6 *

DOI:   http://dx.doi.org/10.1038/s41557-018-0042-7
by applicantWO2004077062
 WO2006078161
 US2008269467
 WO2010062858
 WO2011018227
 WO2011141823
 WO2011163452
 WO2016067035
 WO2017191460
    - GAFFEN, SL, Arthritis Research & Therapy, (20040000), vol. 6, pages 240 - 247
    - SPRIGGS et al., J Clin Immunol, (19970000), vol. 17, pages 366 - 369
    - GAFFEN, SL, Nature Rev Immunol, (20090000), vol. 9, pages 556 - 567
    - DOREAU et al., Nature Immunology, (20090000), vol. 7, pages 778 - 7859
    - APPEL et al., Arthritis Research and Therapy, (20110000), vol. 13, page R95
    - MCLNNES et al., Arthritis & Rheumatism, (20110000), vol. 63, no. 10, page 779
    - JIZHANG, Cancer Immunol Immunother, (20100000), vol. 59, pages 979 - 987
    - ZHANG et al., J Hepatology, (20090000), vol. 50, pages 980 - 89
    - ZHU et al., Breast Cancer Research, (20080000), vol. 10, page R95
    - JIZHANG, Cancer Immunol Immuother, (20100000), vol. 59, pages 979 - 987
    - TUGYI et al., PNAS, (20050000), vol. 102, no. 2, pages 413 - 418
    - SCHREIBER et al., "Rapid, electrostatically assisted association of proteins", Nature Struct. Biol., (19960000), vol. 3, pages 427 - 31
    - GENTILUCCI et al., Curr. Pharmaceutical Design, (20100000), vol. 16, pages 3185 - 203
    - NESTOR et al., Curr. Medicinal Chem, (20090000), vol. 16, pages 4399 - 418
    - Pharmaceutical Salts: Properties, Selection, and Use, (20020800), page 388
    - CHENHARRISON, Biochemical Society Transactions, (20070000), vol. 35, no. 4, page 821
    - GUPTA et al., Advanced Drug Discovery Reviews, (20040000), vol. 57, page 9637
    - DEROSSI et al., J Biol. Chem., (19940000), vol. 269, page 10444
    - OEHLKE et al., Biochim Biophys Acts, (19980000), vol. 1414, page 127
    - OKUYAMA et al., Nature Methods, (20070000), vol. 4, page 153
    - ELSON-SCWAB et al., J Biol Chem, (20070000), vol. 282, page 13585
    - KELLOGG et al., Bioconjugate Chemistry, (20110000), vol. 22, page 717
    - LEFKOVITEPERNIS, Immunological Methods, Academic Press, (19790000), vol. I, II
 GB20170020932
 WO2017EP83953
 WO2017EP83954
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.